Literature DB >> 5694039

Daunomycin inhibition of DNA and RNA synthesis.

A Theologides, J W Yarbro, B J Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5694039     DOI： 10.1002/1097-0142(196801)21:1<16::aid-cncr2820210104>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Metabolism of daunorubicin by a barbiturate-sensitive aldehyde reductase from rat liver.

Authors:  A J Turner; P E Hick
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

Review 2.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  [Estimation of tumor sensitivity in vitro. I. Comparative studies with the Jensen sarcoma in vivo and in vitro after 1-hour-incubation].

Authors:  H J Seidel; L A Wegner
Journal:  Z Krebsforsch       Date:  1969

4.  [Effects of dauno-rubidomycin and adriamycin on enzymes of DNA synthesis in leukocytes in vivo and in culture].

Authors:  K Wilms; W Wilmanns
Journal:  Klin Wochenschr       Date:  1972-09-15

5.  Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.

Authors:  J L Poth; P K Johnson; R P George; S L Schrier
Journal:  Calif Med       Date:  1972-12

6.  Mode of action of chemotherapy in vivo on human acute leukemia. I. Daunomycin.

Authors:  P A Stryckmans; J Manaster; F Lachapelle; M Socquet
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

7.  Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.

Authors:  D Londos-Gagliardi; R Baurain; J Robert; G Aubel-Sadron
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Methylcholanthrene induced murine primitive neuroectodermal tumor: ultrastructure and nuclear RNA polymerase activity.

Authors:  D E Slagel
Journal:  Acta Neuropathol       Date:  1978-12-15       Impact factor: 17.088

9.  Cytofluorescence localization of adriamycin in resistant colon cancer cells.

Authors:  B Chauffert; F Martin; A Caignard; J F Jeannin; A Leclerc
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.

Authors:  N Babudri; B Pani; M Tamaro; C Monti-Bragadin; F Zunino
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.